OPTASE- glycerin solution/ drops

Optase by

Drug Labeling and Warnings

Optase by is a Otc medication manufactured, distributed, or labeled by Scope Health Inc, Oy Finnsusp Ab. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

ACTIVE INGREDIENT

Glycerin 0.9%

KEEP OUT OF REACH OF CHILDREN

Keep Out of Reach of Children

If swallowed, get medical help or contact a poison control center right away.

PURPOSE

Eye Lubricant

WARNINGS

Warning
For external use only.
To avoid contamination, do not touch tip
of container to any surface. After use, shake the bottle
downwards in order to remove any residual drop that
may be left. Replace cap after using.
Do not use the solution if it changes color or becomes
cloudy
Stop use and ask doctor if
You feel eye pain.
Changes in vision occur.
Redness or irritation of the eye lasts.
Condition worsens or lasts more than 72 hours.

INDICATIONS & USAGE

Uses

For use as a lubricant to prevent further irritation.
May be used as a protectant against further irritation.
To relieve dryness of the eye.

DOSAGE & ADMINISTRATION

Directions
Put one or two drops in the affected eyes as needed.

INACTIVE INGREDIENT

Citric Acid Monohydrate, Polyoxyethylenesorbitan Monooleate, Potassium Chloride, Purified Water, Saccha Inchi Seed Oil, Sodium Hyaluronate , Sorbitan Monooleate, Trehalose, Tromethamine

OTHER SAFETY INFORMATION

PRINCIPAL DISPLAY PANEL

INGREDIENTS AND APPEARANCE

OPTASE 
glycerin solution/ drops

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 72972-004
Route of Administration	OPHTHALMIC

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
GLYCERIN (UNII: PDC6A3C0OX) (GLYCERIN - UNII:PDC6A3C0OX)	GLYCERIN	9 mg  in 1 mL

Inactive Ingredients
Ingredient Name	Strength
POLYSORBATE 80 (UNII: 6OZP39ZG8H)
TREHALOSE (UNII: B8WCK70T7I)
HYALURONATE SODIUM (UNII: YSE9PPT4TH)
CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)
WATER (UNII: 059QF0KO0R)
TROMETHAMINE (UNII: 023C2WHX2V)
SORBITAN MONOOLEATE (UNII: 06XEA2VD56)
POTASSIUM CHLORIDE (UNII: 660YQ98I10)
PLUKENETIA VOLUBILIS SEED OIL (UNII: 8ED72Z8J1Z)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 72972-004-01	1 in 1 BOX	02/22/2022
1		10 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M018	02/22/2022

Labeler - Scope Health Inc (116778693)

Registrant - Oy Finnsusp Ab (369374137)